KARACHI: Pakistan Pharmaceutical Manufacturers’ Association (PPMA) has demanded that the entire process of submission of cases by the drug companies for registration and price increase of medicines should be made online to facilitate the industry and for preventing corruption in the system.
Central Chairman, PPPMA, Dr Kaiser Waheed made this demand as he was one of the speakers at launching of a software system by the Drug Regulatory Authority of Pakistan (DRAP) at the DRAP office in Karachi. The software named “Drap-Team” is aimed at online tracking, evaluation, and monitoring of functioning of both the pharmaceutical firms and DRAP field offices in the country.
Dr Waheed cautiously welcomed launching of the software system saying that it was premature on the part of the drug sector regulator to do such an effort until and unless all the processes and subjects of DRAP related to the Pharma industry were made available online.
He said it was not plausible on the part of the DRAP to run a software programme in isolation without making available its entire system online for the applicants of different cases of medicines on behalf of the industry.
“Our biggest issue is that a large part of industry in Pakistan is not so technically competent that it could acquire such a technology on its own. Therefore, this process will take considerable time,” he said.
He said that instances of corruption in the systems of DRAP would be minimized with making online the process for submitting cases by the industry for registration and price increase of medicines.